Ls. Snyder et al., CYCLOPHOSPHAMIDE-INDUCED HEPATOTOXICITY IN A PATIENT WITH WEGENERS GRANULOMATOSIS, Mayo Clinic proceedings, 68(12), 1993, pp. 1203-1204
Cyclophosphamide is widely used in the treatment of many vasculitides.
Hepatotoxicity associated with such therapy is uncommon but possible.
Herein we describe a well-substantiated case of cyclophosphamide-indu
ced hepatotoxicity in a patient with Wegener's granulomatosis. Physici
ans should be aware of this potentially serious reaction when cyclopho
sphamide therapy is initiated. Baseline liver function tests and perio
dic assessment are recommended during treatment with cyclo-phosphamide
.